Cognision
1 known investors
Cognision develops an objective measurement system for evaluating patients with cognitive disorders including concussion, mTBI, and dementia, serving clinicians, pharmaceutical companies, and researchers through brain-based biomarkers and qEEG/ERP testing.
AI & Machine LearningDigital HealthMedical Devices
Investors · 1
In the news
- Kynexis - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2023
- Cognision - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2021
- Cognitive-focused dev Neuronetrix raises $2m - MassDevicemassdevice.com · 2018